Resmed (RMD) Return on Capital Employed (2010 - 2026)

Resmed has reported Return on Capital Employed for 17 years, with the latest figure at 25.95% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 82.0% year-over-year to 25.95%; the trailing twelve-month figure through Mar 2026 stood at 25.95% (up 82.0% YoY), and the FY2025 full-year result was 25.91%, up 355.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 25.95%, up from 25.41% in the prior quarter.
• The five-year high for Return on Capital Employed was 25.95% in Q1 2026, with the low at 18.74% in Q1 2023.
• Historically, Return on Capital Employed has averaged 22.45% across 5 years, with a median of 23.09% in 2024.
• Annual changes were most pronounced in 2023 — Return on Capital Employed sank 501 bps — and 2024, when it soared 583 bps.
• Resmed's Return on Capital Employed stood at 20.13% in 2022, then slipped by 7 bps to 18.82% in 2023, then jumped by 31 bps to 24.65% in 2024, then grew by 3 bps to 25.41% in 2025, then climbed by 2 bps to 25.95% in 2026.
• The last three Return on Capital Employed figures came in at 25.95% (Q1 2026), 25.41% (Q4 2025), and 24.97% (Q3 2025), per Business Quant data.